Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 on the site. This update does not change the study details, eligibility criteria, or outcomes displayed on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision history updated: added Revision v3.4.3 and removed Revision v3.4.2.SummaryDifference0.1%

- Check52 days agoChange DetectedMinor site revision shown as Revision: v3.4.2 replacing v3.4.1; no user-facing content or study information appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision history shows a new entry v3.4.1 and removal of v3.4.0. This is a minor metadata update to the page version.SummaryDifference0.1%

- Check74 days agoChange DetectedUI updates include glossary visibility toggles (Show glossary / Hide glossary) and metadata changes such as Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels with different capitalization and phrasing were replaced.SummaryDifference0.3%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to study content or page layout (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.1%

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.